机构:[1]Center of TCM Preventive Treatment, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, China[2]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China[3]Department of Traditional Chinese Medicine, People’s Hospital of Yangjiang, Yangjiang 529500, China[4]School of Chinese Medicine, Consun Chinese Medicines Research Centre for Renal Diseases, Hong Kong Baptist University, Hong Kong, China[5]Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510515, China南方医科大学珠江医院[6]Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China
This work was supported by the National Natural Science Foundation
of China (No. 82074257, 82174323 and 82004103), the Natural Science
Foundation of Guangdong Province (2019A1515011034,
2023A1515011200 and 2022A1515011668), the Project of Administration of Traditional Chinese Medicine of Guangdong Province
(20232068) and the Scientific Research Fund of People’s Hospital of
Yangjiang (No. G2020001).
第一作者机构:[1]Center of TCM Preventive Treatment, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, China[2]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China
共同第一作者:
通讯作者:
通讯机构:[1]Center of TCM Preventive Treatment, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, China[2]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China[5]Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510515, China[6]Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China[*1]Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China.
推荐引用方式(GB/T 7714):
Diao Jianxin,Fan Huijie,Zhang Jia,et al.Activation of APE1 modulates Nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy[J].INTERNATIONAL IMMUNOPHARMACOLOGY.2024,128:111529.doi:10.1016/j.intimp.2024.111529.
APA:
Diao Jianxin,Fan Huijie,Zhang Jia,Fu Xiuqiong,Liao Rongxin...&Wen Xiaomin.(2024).Activation of APE1 modulates Nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy.INTERNATIONAL IMMUNOPHARMACOLOGY,128,
MLA:
Diao Jianxin,et al."Activation of APE1 modulates Nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy".INTERNATIONAL IMMUNOPHARMACOLOGY 128.(2024):111529